Literature DB >> 18483765

Different distribution of cardiovascular risk factors according to ethnicity: a study in a high risk population.

Fatima El Fakiri1, Marc A Bruijnzeels, Marleen M E Foets, Arno W Hoes.   

Abstract

This study compares the distribution of cardiovascular risk factors in different ethnic groups at high risk of developing cardiovascular diseases within general practices. A total of 430 patients (179 Dutch, 126 Turks, 50 Surinamese, 23 Moroccans, 23 Antilleans and 29 from other ethnic groups) were included in the study. Data collection consisted of questionnaires and physical and clinical examinations. 54% was female. The mean age was 53.1 (sd 9.9) years. There were important ethnic differences in the distribution of cardiovascular risk factors. Compared to the Dutch, ethnic minorities had significantly greater odds of being diabetic (OR = 3.2-19.4); but were less likely to smoke (OR = 0.10-0.53). Turkish individuals had a lower prevalence of hypercholesterolemia but were 2.4 times more likely to be obese than the Dutch. Hypertension was very common in all ethnic groups and no significant ethnic differences were found. These findings provide additional evidence of the need for tailored interventions for different ethnic groups in general practices.

Entities:  

Mesh:

Year:  2008        PMID: 18483765     DOI: 10.1007/s10903-008-9144-4

Source DB:  PubMed          Journal:  J Immigr Minor Health        ISSN: 1557-1912


  27 in total

Review 1.  Prevention of coronary heart disease by diet and lifestyle: evidence from prospective cross-cultural, cohort, and intervention studies.

Authors:  Daan Kromhout; Alessandro Menotti; Hugo Kesteloot; Susana Sans
Journal:  Circulation       Date:  2002-02-19       Impact factor: 29.690

Review 2.  Designing and evaluating interventions to eliminate racial and ethnic disparities in health care.

Authors:  Lisa A Cooper; Martha N Hill; Neil R Powe
Journal:  J Gen Intern Med       Date:  2002-06       Impact factor: 5.128

Review 3.  The impact of ethnicity on type 2 diabetes.

Authors:  Nicola Abate; Manisha Chandalia
Journal:  J Diabetes Complications       Date:  2003 Jan-Feb       Impact factor: 2.852

4.  Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE)

Authors:  S S Anand; S Yusuf; V Vuksan; S Devanesen; K K Teo; P A Montague; L Kelemen; C Yi; E Lonn; H Gerstein; R A Hegele; M McQueen
Journal:  Lancet       Date:  2000-07-22       Impact factor: 79.321

5.  Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention.

Authors:  R Cooper; J Cutler; P Desvigne-Nickens; S P Fortmann; L Friedman; R Havlik; G Hogelin; J Marler; P McGovern; G Morosco; L Mosca; T Pearson; J Stamler; D Stryer; T Thom
Journal:  Circulation       Date:  2000-12-19       Impact factor: 29.690

6.  Women, older persons, and ethnic minorities: factors associated with their inclusion in randomised trials of statins 1990 to 2001.

Authors:  C Bartlett; P Davey; P Dieppe; L Doyal; S Ebrahim; M Egger
Journal:  Heart       Date:  2003-03       Impact factor: 5.994

7.  Meta-analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes.

Authors:  Bernard M Y Cheung; Ian J Lauder; Chu-Pak Lau; Cyrus R Kumana
Journal:  Br J Clin Pharmacol       Date:  2004-05       Impact factor: 4.335

8.  Smoking reduction, smoking cessation, and incidence of fatal and non-fatal myocardial infarction in Denmark 1976-1998: a pooled cohort study.

Authors:  N S Godtfredsen; M Osler; J Vestbo; I Andersen; E Prescott
Journal:  J Epidemiol Community Health       Date:  2003-06       Impact factor: 3.710

Review 9.  Perspectives on coronary heart disease in African Americans.

Authors:  Laurence O Watkins
Journal:  Rev Cardiovasc Med       Date:  2004       Impact factor: 2.930

10.  Disparities in lipid management for African Americans and Caucasians with coronary artery disease: a national cross-sectional study.

Authors:  Mark W Massing; Kathleen A Foley; Lori Carter-Edwards; Carla A Sueta; Charles M Alexander; Ross J Simpson
Journal:  BMC Cardiovasc Disord       Date:  2004-08-18       Impact factor: 2.298

View more
  11 in total

1.  2016 European Guidelines on cardiovascular disease prevention in clinical practice : The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts).

Authors:  Massimo F Piepoli
Journal:  Int J Behav Med       Date:  2017-06

2.  2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).

Authors:  Massimo F Piepoli; Arno W Hoes; Stefan Agewall; Christian Albus; Carlos Brotons; Alberico L Catapano; Marie-Therese Cooney; Ugo Corrà; Bernard Cosyns; Christi Deaton; Ian Graham; Michael Stephen Hall; F D Richard Hobbs; Maja-Lisa Løchen; Herbert Löllgen; Pedro Marques-Vidal; Joep Perk; Eva Prescott; Josep Redon; Dimitrios J Richter; Naveed Sattar; Yvo Smulders; Monica Tiberi; H Bart van der Worp; Ineke van Dis; W M Monique Verschuren; Simone Binno
Journal:  Eur Heart J       Date:  2016-05-23       Impact factor: 29.983

3.  Feasibility and effectiveness of a targeted diabetes prevention program for 18 to 60-year-old South Asian migrants: design and methods of the DH!AAN study.

Authors:  Everlina M A Vlaar; Irene G M van Valkengoed; Vera Nierkens; Mary Nicolaou; Barend J C Middelkoop; Karien Stronks
Journal:  BMC Public Health       Date:  2012-05-23       Impact factor: 3.295

4.  Cardiovascular Health and Related Health Care Use of Moluccan-Dutch Immigrants.

Authors:  Tim R de Back; Adee J Bodewes; Lizzy M Brewster; Anton E Kunst
Journal:  PLoS One       Date:  2015-09-22       Impact factor: 3.240

5.  The Uptake of Screening for Type 2 Diabetes and Prediabetes by Means of Glycated Hemoglobin versus the Oral Glucose Tolerance Test among 18 to 60-Year-Old People of South Asian Origin: A Comparative Study.

Authors:  Irene G M van Valkengoed; Everlina M A Vlaar; Vera Nierkens; Barend J C Middelkoop; Karien Stronks
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

6.  Pharmacoepidemiological Data from Drug Dispensing Charities as a Measure of Health Patterns in a Population not Assisted by the Italian National Health Service.

Authors:  Silvia Bini; Cesare Cerri; Antonello E Rigamonti; Pietro A Bertazzi; Gianfrancesco Fiorini; Silvano G Cella
Journal:  J Public Health Res       Date:  2016-08-19

7.  Ethnic differences in cardiovascular morbidity and mortality among patients with breast cancer in the Netherlands: a register-based cohort study.

Authors:  Laura Deen; Josefien Buddeke; Ilonca Vaartjes; Michiel L Bots; Marie Norredam; Charles Agyemang
Journal:  BMJ Open       Date:  2018-08-17       Impact factor: 2.692

8.  Ethnic differences in cardiometabolic risk profile at age 5-6 years: the ABCD study.

Authors:  Marieke L A de Hoog; Manon van Eijsden; Karien Stronks; Reinoud J B J Gemke; Tanja G M Vrijkotte
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

9.  Ethnic differences in prevalence and risk factors for hypertension in the Suriname Health Study: a cross sectional population study.

Authors:  Ingrid S K Krishnadath; Vincent W V Jaddoe; Lenny M Nahar-van Venrooij; Jerry R Toelsie
Journal:  Popul Health Metr       Date:  2016-09-17

10.  Ethnic disparities in estimated cardiovascular disease risk in Amsterdam, the Netherlands : The HELIUS study.

Authors:  W Perini; M B Snijder; R J G Peters; A E Kunst
Journal:  Neth Heart J       Date:  2018-05       Impact factor: 2.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.